Cardiovascular calcification is a growing burden and a leading contributor to acute cardiovascular events, but no therapeutics are currently available. Recently, Choi et al. [(1)][1] put forward dipeptidyl peptidase (DPP)-4 as… Click to show full abstract
Cardiovascular calcification is a growing burden and a leading contributor to acute cardiovascular events, but no therapeutics are currently available. Recently, Choi et al. [(1)][1] put forward dipeptidyl peptidase (DPP)-4 as a new pharmacological target to prevent aortic valve calcification. DPP-
               
Click one of the above tabs to view related content.